A new study has revealed a new molecular map that could explain the link between cancer and diabetes. It is hoped the map will offer a better understanding of the cancer risk that people suffering from type 2 diabetes face.
The research, carried out at Lund University in Sweden and published in the journal Human Molecular Genetics, uncovered a map of molecules that showed some of the reasons behind why people with diabetes have an increased likelihood of developing some types of cancer.
The team found that because there are long and complex phases for the development of type 2 diabetes, this provides more time for genes that are risky to the potential for cancer, called TCF and p53, to become prominent.
The two genes combine during the onset of diabetes, with TCF helping to defend against cell death and p53 preventing excessive cell division, a process that increases cancer risk. It is known that the risk variant of TCF is comparatively common, as 25 per cent of the general population carry it, while this rises to 31 per cent for diabetes patients.
Yuedan Zhou, lead author on the study, commented “We have worked with the most well-known risk gene for type 2 diabetes – a variant of the TCF gene – and have studied its function in the beta cells.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…